227 related articles for article (PubMed ID: 30677252)
1. Incremental cost-effectiveness of evidence-based non-surgical weight loss strategies.
Finkelstein EA; Verghese NR
Clin Obes; 2019 Apr; 9(2):e12294. PubMed ID: 30677252
[TBL] [Abstract][Full Text] [Related]
2. Meta- and cost-effectiveness analysis of commercial weight loss strategies.
Finkelstein EA; Kruger E
Obesity (Silver Spring); 2014 Sep; 22(9):1942-51. PubMed ID: 24962106
[TBL] [Abstract][Full Text] [Related]
3. Cost-Effectiveness Analysis of Qsymia for Weight Loss.
Finkelstein EA; Kruger E; Karnawat S
Pharmacoeconomics; 2015 Jul; 33(7):699-706. PubMed ID: 24986038
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.
Lacey LA; Wolf A; O'shea D; Erny S; Ruof J
Int J Obes (Lond); 2005 Aug; 29(8):975-82. PubMed ID: 15852050
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Diet and Exercise for Overweight and Obese Patients With Knee Osteoarthritis.
Losina E; Smith KC; Paltiel AD; Collins JE; Suter LG; Hunter DJ; Katz JN; Messier SP
Arthritis Care Res (Hoboken); 2019 Jul; 71(7):855-864. PubMed ID: 30055077
[TBL] [Abstract][Full Text] [Related]
6. The cost-effectiveness of primary care referral to a UK commercial weight loss programme.
Meads DM; Hulme CT; Hall P; Hill AJ
Clin Obes; 2014 Dec; 4(6):324-32. PubMed ID: 25826162
[TBL] [Abstract][Full Text] [Related]
7. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial.
Ahern AL; Wheeler GM; Aveyard P; Boyland EJ; Halford JCG; Mander AP; Woolston J; Thomson AM; Tsiountsioura M; Cole D; Mead BR; Irvine L; Turner D; Suhrcke M; Pimpin L; Retat L; Jaccard A; Webber L; Cohn SR; Jebb SA
Lancet; 2017 Jun; 389(10085):2214-2225. PubMed ID: 28478041
[TBL] [Abstract][Full Text] [Related]
8. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
9. Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.
Griffiths UK; Anigbogu B; Nanchahal K
Appl Health Econ Health Policy; 2012 May; 10(3):145-62. PubMed ID: 22439628
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of lifestyle intervention in obese infertile women.
van Oers AM; Mutsaerts MAQ; Burggraaff JM; Kuchenbecker WKH; Perquin DAM; Koks CAM; van Golde R; Kaaijk EM; Schierbeek JM; Klijn NF; van Kasteren YM; Land JA; Mol BWJ; Hoek A; Groen H;
Hum Reprod; 2017 Jul; 32(7):1418-1426. PubMed ID: 28486704
[TBL] [Abstract][Full Text] [Related]
11. The cost effectiveness of orlistat in a 1-year weight-management programme for treating overweight and obese patients in Sweden : a treatment responder approach.
Hertzman P
Pharmacoeconomics; 2005; 23(10):1007-20. PubMed ID: 16235974
[TBL] [Abstract][Full Text] [Related]
12. Diet, drugs, devices, and surgery for weight management.
Med Lett Drugs Ther; 2018 Jun; 60(1548):91-98. PubMed ID: 29913463
[No Abstract] [Full Text] [Related]
13. Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.
Zomer E; Leach R; Trimmer C; Lobstein T; Morris S; James WP; Finer N
Diabetes Obes Metab; 2017 Jan; 19(1):118-124. PubMed ID: 27649286
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of a low-calorie diet and orlistat for obese persons: modeling long-term health gains through prevention of obesity-related chronic diseases.
van Baal PH; van den Berg M; Hoogenveen RT; Vijgen SM; Engelfriet PM
Value Health; 2008 Dec; 11(7):1033-40. PubMed ID: 18494748
[TBL] [Abstract][Full Text] [Related]
15. The effect of weight management interventions that include a diet component on weight-related outcomes in pregnant and postpartum women: a systematic review protocol.
Spencer L; Rollo M; Hauck Y; MacDonald-Wicks L; Wood L; Hutchesson M; Giglia R; Smith R; Collins C
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):88-98. PubMed ID: 26447010
[TBL] [Abstract][Full Text] [Related]
16. Cost-utility analysis of rimonabant in the treatment of obesity.
Hampp C; Hartzema AG; Kauf TL
Value Health; 2008; 11(3):389-99. PubMed ID: 18179661
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of a primary care intervention to treat obesity.
Tsai AG; Wadden TA; Volger S; Sarwer DB; Vetter M; Kumanyika S; Berkowitz RI; Diewald LK; Perez J; Lavenberg J; Panigrahi ER; Glick HA
Int J Obes (Lond); 2013 Aug; 37 Suppl 1(0 1):S31-7. PubMed ID: 23921780
[TBL] [Abstract][Full Text] [Related]
18. Economic evaluation of orlistat in overweight and obese patients with type 2 diabetes mellitus.
Maetzel A; Ruof J; Covington M; Wolf A
Pharmacoeconomics; 2003; 21(7):501-12. PubMed ID: 12696990
[TBL] [Abstract][Full Text] [Related]
19. A within-trial cost-effectiveness analysis of primary care referral to a commercial provider for weight loss treatment, relative to standard care--an international randomised controlled trial.
Fuller NR; Colagiuri S; Schofield D; Olson AD; Shrestha R; Holzapfel C; Wolfenstetter SB; Holle R; Ahern AL; Hauner H; Jebb SA; Caterson ID
Int J Obes (Lond); 2013 Jun; 37(6):828-34. PubMed ID: 22929209
[TBL] [Abstract][Full Text] [Related]
20. Rimonabant for the treatment of overweight and obese people.
Burch J; McKenna C; Palmer S; Norman G; Glanville J; Sculpher M; Woolacott N
Health Technol Assess; 2009 Oct; 13 Suppl 3():13-22. PubMed ID: 19846024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
